Giant Biogene Holding Co. Ltd.(HK:2367)
HK$19.68-0.78 (-3.81%)
HK:2367
Giant Biogene Holding Co. Ltd. financials statements
HK$19.68
At close:-0.78 (-3.81%)
Want to see HK:2367 full AI Analyst Report?
Giant Biogene Holding Co. Ltd. (2367) Financial Statements
11 Followers
Giant Biogene Holding Co. Ltd. Financial Overview
Giant Biogene Holding Co. Ltd.'s market cap is currently ¥22.33B. The company's EPS TTM is ¥1.56; its P/E ratio is 11.16; and it has a dividend yield of 2.90%. Giant Biogene Holding Co. Ltd. is estimated to report earnings on March 29, 2027, and the estimated EPS forecast is ¥1.03. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 5.52B | ¥ 5.54B | ¥ 3.52B | ¥ 2.36B | ¥ 1.55B |
| Gross Profit | ¥ 4.43B | ¥ 4.55B | ¥ 2.95B | ¥ 2.00B | ¥ 1.35B |
| Operating Income | ¥ 2.12B | ¥ 2.31B | ¥ 1.66B | ¥ 1.13B | ¥ 914.57M |
| EBITDA | ¥ 2.20B | ¥ 2.33B | ¥ 1.78B | ¥ 1.21B | ¥ 934.78M |
| Net Income | ¥ 1.91B | ¥ 2.06B | ¥ 1.45B | ¥ 1.00B | ¥ 828.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 8.29B | ¥ 5.86B | ¥ 3.78B | ¥ 2.20B | ¥ 7.26B |
| Total Assets | ¥ 10.85B | ¥ 8.04B | ¥ 4.97B | ¥ 3.14B | ¥ 7.88B |
| Total Debt | ¥ 9.69M | ¥ 6.71M | ¥ 2.73M | ¥ 2.59M | ¥ 7.68B |
| Net Debt | ¥ -6.30B | ¥ -4.02B | ¥ -2.50B | ¥ -1.33B | ¥ -7.10B |
| Total Liabilities | ¥ 917.03M | ¥ 918.14M | ¥ 602.03M | ¥ 301.19M | ¥ 6.86B |
| Stockholders' Equity | ¥ 9.92B | ¥ 7.11B | ¥ 4.36B | ¥ 2.83B | ¥ 1.02B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 1.48B | ¥ 1.79B | ¥ 1.42B | ¥ 778.39M | ¥ 581.21M |
| Operating Cash Flow | ¥ 1.90B | ¥ 2.04B | ¥ 1.65B | ¥ 931.64M | ¥ 692.40M |
| Investing Cash Flow | ¥ -471.99M | ¥ -1.11B | ¥ -527.28M | ¥ -858.74M | ¥ 1.56B |
| Financing Cash Flow | ¥ 892.40M | ¥ 582.95M | ¥ 51.81M | ¥ -5.79B | ¥ 4.48B |
Currency in CNY
